In July, a team of scientists led by synthetic biologist Kate Adamala at the University of Minnesota unveiled SpudCell, a synthetic cell created entirely from lifeless materials. This red, spherical cell can grow, replicate its DNA, and divide, marking what some experts describe as the closest science has come to manufacturing life from scratch. The emergence of SpudCell raises significant scientific, ethical, and security questions about the future of synthetic biology.

Adamala and three colleagues founded a nonprofit organization called Biotic to support ongoing research into SpudCell. At a recent meeting in Philadelphia, dubbed Bloomsday, researchers, ethicists, biotech industry representatives, and government officials convened to discuss how to develop and safely apply this synthetic cell technology. The event focused on the foundational work needed to create a self-sustaining, engineered cell that could be widely used to produce medicines, foods, and fuels not easily made by conventional biological systems.

Despite excitement around SpudCell’s potential, some in the scientific community remain skeptical. Cees Dekker, a physicist at Delft University of Technology, critiqued the project’s early stage, noting that although SpudCell was engineered with 36 genes, only one appeared active in experiments. Additionally, a key paper by Adamala’s team was initially rejected by the journal Cell and is currently available only as a preprint while under consideration by another journal.

Creating a fully autonomous synthetic cell remains a major challenge. Unlike natural cells, which can produce their own molecular machinery such as ribosomes, SpudCells must be supplied with ribosomes harvested from living cells, which degrade over time. Researchers like Yoshiru Shimizu at RIKEN in Japan are investigating ways to enable ribosomes to self-assemble within SpudCells. Other scientists are exploring methods to improve cell division accuracy or to control gene activation through light sensitivity.

To manage the complexity, computational biologist Roseanna Zia at the University of Missouri is building highly detailed computer simulations of SpudCell’s molecular components. Her virtual model aims to streamline the process of designing synthetic cells that can be reliably produced in laboratories, following open protocols developed by Biotic.

The team envisions SpudCell as an open, easily engineered platform for synthetic biology, analogous to the Unix operating system that revolutionized computer science through accessibility and community collaboration. However, ethical and security concerns remain prominent. Bioethicist Laurie Zoloth of the University of Chicago highlighted the difficulty in defining what constitutes “life” and the potential risks of public mistrust or misuse of this technology. To mitigate such risks, Adamala's group has engineered SpudCell’s DNA and proteins to require an unnatural chemical environment, preventing survival outside controlled laboratory settings and minimizing the chance of their use as biological weapons.

While the scientific community continues to debate SpudCell’s significance and prospects, its developers emphasize cautious progress. “We can safeguard biology on the most fundamental level,” Adamala said. Drew Endy, a Stanford University synthetic biologist and Biotic co-founder, acknowledged the uncertainties ahead, stating, “We’ll take all the good karma and good luck we can get. We’re going to need it.”